117 related articles for article (PubMed ID: 15530292)
1. Treatment of HIV-associated facial lipoatrophy with Radiance FN (Radiesse).
Comite SL; Liu JF; Balasubramanian S; Christian MA
Dermatol Online J; 2004 Oct; 10(2):2. PubMed ID: 15530292
[TBL] [Abstract][Full Text] [Related]
2. A ribose-crosslinked collagen filler treatment for facial lipoatrophy associated with the treatment of human immunodeficiency virus.
Reytan N; Rzany B
J Drugs Dermatol; 2008 Dec; 7(12):1169-71. PubMed ID: 19137772
[TBL] [Abstract][Full Text] [Related]
3. Porcine filler for facial lipoatrophy associated with human immunodeficiency virus treatment.
Reytan N; Rzany B
J Drugs Dermatol; 2008 Sep; 7(9):884-6. PubMed ID: 19112805
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus.
Carruthers A; Carruthers J
Dermatol Surg; 2008 Nov; 34(11):1486-99. PubMed ID: 18811715
[TBL] [Abstract][Full Text] [Related]
5. A case of HIV-associated facial lipoatrophy treated with 1000-cs liquid injectable silicone.
Orentreich D; Leone AS
Dermatol Surg; 2004 Apr; 30(4 Pt 1):548-51. PubMed ID: 15056149
[TBL] [Abstract][Full Text] [Related]
6. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
[TBL] [Abstract][Full Text] [Related]
7. A comparison of lipoatrophy and aging: volume deficits in the face.
Coleman S; Saboeiro A; Sengelmann R
Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
[TBL] [Abstract][Full Text] [Related]
8. Contemporary surgical management of HIV-associated facial lipoatrophy.
Funk E; Bressler FJ; Brissett AE
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):1015-22. PubMed ID: 16730549
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients.
Karim RB; de Lint CA; van Galen SR; van Rozelaar L; Nieuwkerk PT; Askarizadeh E; Hage JJ
Aesthetic Plast Surg; 2008 Nov; 32(6):873-8. PubMed ID: 18551339
[TBL] [Abstract][Full Text] [Related]
10. Cost consequences of HIV-associated lipoatrophy.
Hornberger J; Rajagopalan R; Shewade A; Loutfy MR
AIDS Care; 2009 May; 21(5):664-71. PubMed ID: 19444676
[TBL] [Abstract][Full Text] [Related]
11. Treatment of facial lipoatrophy via autologous fat transfer.
Cohen G; Treherne A
J Drugs Dermatol; 2009 May; 8(5):486-9. PubMed ID: 19537373
[TBL] [Abstract][Full Text] [Related]
12. Radiance FN: a new soft tissue filler.
Sklar JA; White SM
Dermatol Surg; 2004 May; 30(5):764-8; discussion 768. PubMed ID: 15099322
[TBL] [Abstract][Full Text] [Related]
13. Comparison between lipofilling and a nonabsorbable filler for facial wasting rehabilitation in HIV-positive patients.
Rauso R; Curinga G; Santillo V; Corvo G; Tartaro G
J Craniofac Surg; 2011 Sep; 22(5):1684-8. PubMed ID: 21959413
[TBL] [Abstract][Full Text] [Related]
14. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability.
Silvers SL; Eviatar JA; Echavez MI; Pappas AL
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):34S-45S. PubMed ID: 16936543
[TBL] [Abstract][Full Text] [Related]
15. HIV-associated facial lipoatrophy--review of current therapy options.
Bechara FG; Sand M; Potthoff A; Altmeyer P; Brockmeyer NH;
Eur J Med Res; 2008 Mar; 13(3):93-9. PubMed ID: 18499554
[TBL] [Abstract][Full Text] [Related]
16. Facial fat volume in HIV-infected patients with lipoatrophy.
Yang Y; Sitoh YY; Oo Tha N; Paton NI
Antivir Ther; 2005; 10(4):575-81. PubMed ID: 16038484
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
[TBL] [Abstract][Full Text] [Related]
18. Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation.
Guaraldi G; De Fazio D; Orlando G; Murri R; Wu A; Guaraldi P; Esposito R
Clin Infect Dis; 2005 Jan; 40(2):e13-5. PubMed ID: 15655734
[TBL] [Abstract][Full Text] [Related]
19. Preliminary experiences with Bio-Alcamid in HIV facial lipoatrophy.
Ramon Y; Fodor L; Ullmann Y
Dermatology; 2007; 214(2):151-4. PubMed ID: 17341865
[TBL] [Abstract][Full Text] [Related]
20. HIV-associated facial lipoatrophy treated with injectable silicone oil: a pilot study.
Chen F; Carruthers A; Humphrey S; Carruthers J
J Am Acad Dermatol; 2013 Sep; 69(3):431-7. PubMed ID: 23711767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
